Agencies

The clinical team, who delivered a small dose of the vaccine to the participant at a west London facility, are closely monitoring the participant and report they are in good health, with no safety concerns.

The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday.

The clinical team, who delivered a small dose of the vaccine to the participant at a west London facility, are closely monitoring the participant and report they are in good health, with no safety concerns.

The human trials of the vaccine are also the first test of a new self-amplifying RNA (saRNA) technology.

"We have reached a significant milestone in this ground-breaking study with the first dose of a self-amplifying RNA vaccine delivered safely," said Dr Katrina Pollock, from Imperial's Department of Infectious Disease and Chief Investigator of the study.